Reducing laboratory errors in pre-pre-analytical phase with navify® Sample Transport*
Success story
CBT Bonn
Leading healthcare provider in Germany with over 40 years of expertise
Operating across six sites
Processes samples from nearly 3,000 doctors and offers a range of outpatient and laboratory medicine services, including haematology, immunology, cytology, molecular diagnostics and endocrinology.
Reducing laboratory errors in pre-pre-analytical phase with navify Sample Transport
The Center for Blood Clotting Disorders and Transfusion Medicine in Bonn, Germany, collaborated with Roche Diagnostics and the start-up Smart4Diagnostics (S4DX) to create navify Sample Transport. This cloud-based software solution allows for efficient monitoring of patient samples from initial sampling to laboratory analysis.
Would you like to learn more?
Get in touch with our sales team.
Laboratories are all about delivering accurate, useful data, but some things are outside their control
Approximately 62% of errors in laboratory diagnostics occur in the pre-pre-analytical phase1, between the moment samples are collected and received by the lab. Many providers of digital solutions are trying to help laboratories address this significant challenge. However, there has been no comprehensive solution that focuses on the end-to-end pre-pre-analytical process — until now. Watch the video: Dr. André Körner answers 5 key questions on culture, innovation and transformation at CBT.
Higher testing quality enabled by greater process transparency
In designing this project, the three collaborators examined the complete process for the collection and transport of blood samples. This included original sample collection, transportation, checking and recording patient data for sample collection (e.g. time of collection).
With navify Sample Transport, CBT was able to combine all sample-relevant pre-pre-analytical data, even if the data originated from different digital tools or suppliers, and connect this data directly with the laboratory information system (LIS).
The result was greater visibility into potential sources of testing errors, enabling laboratory managers to take prompt action, when necessary, to protect the integrity of sample quality and, ultimately, the quality of test results.
Significant reduction of errors in pre-pre-analytical phase
In the eight-month pilot phase of navify Sample Transport, 60,000 patient samples were successfully digitized. In extensive test runs, the CBT project team compared error rates when using navify Sample Transport with the average error rates in pre-pre-analytical phase. The results were clear: navify Sample Transport produced significant improvements by reducing errors in sample filling, incorrect patient assignments and misinterpreted orders. In addition, because navify Sample Transport produces a unique digital stamp for each sample, including time of blood collection, control for each orders’ completeness was automated and made more reliable. Above all, it eliminated confusion between samples — a highly relevant result given the previous error rate of nine percent during patient identification.
Results
Significant error reduction
0%within 2.25 years of implementing
0%within 2.25 years of implementing
0.02%within 2.25 years of implementing
2.31%within 2.25 years of implementing
For us, navify Sample Transport is an essential part of value-based healthcare (VBHC) – just like the outcome measures reported by patients and collected by doctors. We are convinced that with navify Sample Transport and other developments, we are making important contributions to VBHC.
- Cadamuro J, Gaksch M, Mrazek C, Haschke-Becher E, Plebani M. How do we use the data from pre-analytical quality indicators and how should we? J Lab Precis Med. 2018;3(6). DOI:10.21037/jlpm.2018.04.04.
- Not every digital product is available in all markets. The use of any third-party app is subject to a separate license agreement with the respective third-party app developer. Roche gives no warranties (express or implied) with regard to any third-party app. Third-party apps might not be available in your country. This website and its content may be accessible worldwide, Roche assumes no liability with regard to the access to the information, which may not be compatible with legislations or regulations in force in your country.
- *navify® Sample Transport was formerly known as navify Sample Tracking. The case study was conducted in 2023, when the product was marketed under its previous name. The name navify Sample Transport was introduced in early 2026.